Preventing non bacteremic pneumococcal pneumonia in older adults

Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older: United States, 2014*

(2014) Carolyn B. Bridges et al.   ANNALS OF INTERNAL MEDICINE

Editorial Commentary: A Tale of 2 Pneumococcal Vaccines

(2014) K. P. Klugman   CLINICAL INFECTIOUS DISEASES

Early Impact of 13-Valent Pneumococcal Conjugate Vaccine on Community-Acquired Pneumonia in Children

(2014) F. Angoulvant et al.   CLINICAL INFECTIOUS DISEASES

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged >=60 Years: 3 Years of Follow-up in the CAPAMIS Study

(2014) O. Ochoa-Gondar et al.   CLINICAL INFECTIOUS DISEASES

Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England

(2014) Albert Jan van Hoek et al.   VACCINE

Clinical features of adults with seven-valent-conjugated-vaccine-serotype pneumococcal pneumonia

(2014) Chamira Rodrigo et al.   VACCINE

The stubborn persistence of adult pneumococcal pneumonia as a public health problem

(2014) Rosalind Hollingsworth et al.   Human Vaccines & Immunotherapeutics

Using Pneumococcal Carriage Data to Monitor Postvaccination Changes in Invasive Disease

(2013) Daniel M. Weinberger et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia

(2013) Susanne M. Huijts et al.   EUROPEAN RESPIRATORY JOURNAL

Distribution of Pneumococcal Serotypes in Adult Pneumococcal Pneumonia Cases: Filling the Evidence Gap to Inform Vaccination Policies

(2013) M. R. Griffin et al.   JOURNAL OF INFECTIOUS DISEASES

Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged >=50 Years With Community-Acquired Pneumonia

(2013) R. L. Sherwin et al.   JOURNAL OF INFECTIOUS DISEASES

U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination

(2013) Marie R. Griffin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nearly Complete Elimination of the 7-valent Pneumococcal Conjugate Vaccine Serotypes in Tennessee

(2013) Natasha B. Halasa et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine

(2013) Sheldon L. Kaplan et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Systematic Review of the Indirect Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Pneumococcal Disease and Colonization

(2013) Jennifer D. Loo et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Prevention of Pneumonia

(2013) Jennifer D. Loo et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage

(2013) Katherine E. Fleming-Dutra et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Invasive Pneumococcal Disease Among Young Children

(2013) Laura Conklin et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Estimating the Burden of Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis of Diagnostic Techniques

(2013) Maria A. Said et al.   PLoS One

Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines

(2013) Thomas Benfield et al.   PLoS One

Pneumococcal serotypes in adult non-invasive and invasive pneumonia in relation to child contact and child vaccination status

(2013) Chamira Rodrigo et al.   THORAX

Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: Review of evidence on indirect effects

(2013) Stephanie M. Davis et al.   VACCINE

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

(2013) Lisa A. Jackson et al.   VACCINE

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults

(2013) Lisa A. Jackson et al.   VACCINE

Forecasting invasive pneumococcal disease trends after the introduction of 13-valent pneumococcal conjugate vaccine in the United States, 2010–2020

(2013) Ruth Link-Gelles et al.   VACCINE

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway

(2013) Anneke Steens et al.   VACCINE

Pneumococcal conjugate vaccination for older adults

(2013) David S Fedson   Human Vaccines & Immunotherapeutics

Pneumococcal vaccination of older adults

(2013) Rosalind Hollingsworth et al.   Human Vaccines & Immunotherapeutics

Pneumococcal vaccination of older adults

(2013) David S. Fedson et al.   Human Vaccines & Immunotherapeutics

Carriage ofStreptoccoccus pneumoniaein healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children

(2013) Filippo Ansaldi et al.   Human Vaccines & Immunotherapeutics

Pneumococcal Polysaccharide Vaccine Efficacy and Routine Use of Conjugate Vaccines in Infants: There Is No Need for a Vaccine Program in Older Adults at Present

(2012) J. Truck et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of Invasive Pneumococcal Disease Among High-Risk Adults Since the Introduction of Pneumococcal Conjugate Vaccine for Children

(2012) R. D. Muhammad et al.   CLINICAL INFECTIOUS DISEASES

Impact of the 7-valent pneumococcal conjugate vaccine on the incidence of childhood pneumonia

(2012) M. A. ELEMRAID et al.   EPIDEMIOLOGY AND INFECTION

The fundamental link between pneumococcal carriage and disease

(2012) Birgit Simell et al.   Expert Review of Vaccines

Cost-effectiveness of Adult Vaccination Strategies Using Pneumococcal Conjugate Vaccine Compared With Pneumococcal Polysaccharide Vaccine

(2012) Kenneth J. Smith et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pneumococcal Carriage and Invasive Disease in Children Before Introduction of the 13-valent Conjugate Vaccine

(2012) Dolly Sharma et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Nasopharyngeal carriage of Streptococcus pneumoniae and pneumococcal urine antigen test in healthy elderly subjects

(2012) Arto A. Palmu et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia

(2012) Thomas Bewick et al.   THORAX

Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50years

(2012) Derek Weycker et al.   VACCINE

Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales

(2012) Nick J. Andrews et al.   VACCINE

A Randomized Study Comparing Combined Pneumococcal Conjugate and Polysaccharide Vaccination Schedules in Adults

(2011) R. Lazarus et al.   CLINICAL INFECTIOUS DISEASES

Pneumococcal polysaccharide vaccination for adults: new perspectives for Europe

(2011) David S Fedson et al.   Expert Review of Vaccines

Cost effectiveness of child pneumococcal conjugate vaccination in middle-income countries

(2011) Mari M. Nakamura et al.   International Health

Efficacy of pneumococcal vaccination in adults: a meta-analysis

(2009) A. Huss et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine

(2009) Tamara Pilishvili et al.   JOURNAL OF INFECTIOUS DISEASES